Pharmacokinetic and Immunological Considerations for Expanding the Therapeutic Window of Next-Generation Antibody–Drug Conjugates
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetic and Immunological Considerations for Expanding the Therapeutic Window of Next-Generation Antibody–Drug Conjugates
Authors
Keywords
-
Journal
BIODRUGS
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-21
DOI
10.1007/s40259-018-0302-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Two-Step Immunocapture LC/MS/MS Assay for Plasma Stability and Payload Migration Assessment of Cysteine–Maleimide-Based Antibody Drug Conjugates
- (2018) Linlin Dong et al. ANALYTICAL CHEMISTRY
- High-Throughput Cysteine Scanning To Identify Stable Antibody Conjugation Sites for Maleimide- and Disulfide-Based Linkers
- (2018) Rachana Ohri et al. BIOCONJUGATE CHEMISTRY
- Modulating Antibody–Drug Conjugate Payload Metabolism by Conjugation Site and Linker Modification
- (2018) Dian Su et al. BIOCONJUGATE CHEMISTRY
- Site-Specific Antibody Functionalization Using Tetrazine–Styrene Cycloaddition
- (2018) Benjamin J. Umlauf et al. BIOCONJUGATE CHEMISTRY
- Fc-Mediated Anomalous Biodistribution of Therapeutic Antibodies in Immunodeficient Mouse Models
- (2018) Sai Kiran Sharma et al. CANCER RESEARCH
- Digital spatial profiling platform allows for spatially-resolved, multiplexed measurement of solid tumor protein distribution and abundance in FFPE tissue sections
- (2018) A. Winfield EUROPEAN JOURNAL OF CANCER
- Establishing in vitro–in vivo correlation for antibody drug conjugate efficacy: a PK/PD modeling approach
- (2018) Dhaval K. Shah et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- A mathematical model of antibody-dependent cellular cytotoxicity (ADCC)
- (2018) F. Hoffman et al. JOURNAL OF THEORETICAL BIOLOGY
- Intratumoral Payload Concentration Correlates with the Activity of Antibody–Drug Conjugates
- (2018) Donglu Zhang et al. MOLECULAR CANCER THERAPEUTICS
- Site-Specifically Labeled Antibody–Drug Conjugate for Simultaneous Therapy and ImmunoPET
- (2018) Pierre Adumeau et al. MOLECULAR PHARMACEUTICS
- Toward a Ferrous Iron-Cleavable Linker for Antibody–Drug Conjugates
- (2018) Benjamin Spangler et al. MOLECULAR PHARMACEUTICS
- Development of a Small Molecule Tubulysin B Conjugate for Treatment of Carbonic Anhydrase IX Receptor Expressing Cancers
- (2018) Isaac S. Marks et al. MOLECULAR PHARMACEUTICS
- Antibody drug conjugates for treatment of breast cancer: Novel targets and diverse approaches in ADC design
- (2018) Pamela A. Trail et al. PHARMACOLOGY & THERAPEUTICS
- Functional relevance of in vivo half antibody exchange of an IgG4 therapeutic antibody-drug conjugate
- (2018) Peter Herbener et al. PLoS One
- Immunogenicity considerations for antibody–drug conjugates: a focus on neutralizing antibody assays
- (2018) Corinna K Fiorotti Bioanalysis
- Reduction–rebridging strategy for the preparation of ADPN-based antibody–drug conjugates
- (2018) Oleksandr Koniev et al. MedChemComm
- Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice
- (2018) Raffaella Rossin et al. Nature Communications
- Mathematical modeling of tumor-associated macrophage interactions with the cancer microenvironment
- (2018) Grace Mahlbacher et al. Journal for ImmunoTherapy of Cancer
- Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice
- (2017) Megan Lo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Modulation of drug-linker design to enhance in vivo potency of homogeneous antibody-drug conjugates
- (2017) Martin Pabst et al. JOURNAL OF CONTROLLED RELEASE
- Distribution of FcRn Across Species and Tissues
- (2017) Sari Latvala et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Preclinical Evaluation of MEDI0641, a Pyrrolobenzodiazepine-Conjugated Antibody–Drug Conjugate Targeting 5T4
- (2017) Jay Harper et al. MOLECULAR CANCER THERAPEUTICS
- Modulating Therapeutic Activity and Toxicity of Pyrrolobenzodiazepine Antibody–Drug Conjugates with Self-Immolative Disulfide Linkers
- (2017) Thomas H. Pillow et al. MOLECULAR CANCER THERAPEUTICS
- Tumor-Associated Macrophages Can Contribute to Antitumor Activity through FcγR-Mediated Processing of Antibody–Drug Conjugates
- (2017) Fu Li et al. MOLECULAR CANCER THERAPEUTICS
- Tracking Antibody Distribution with Near-Infrared Fluorescent Dyes: Impact of Dye Structure and Degree of Labeling on Plasma Clearance
- (2017) Cornelius Cilliers et al. MOLECULAR PHARMACEUTICS
- Next generation antibody drugs: pursuit of the 'high-hanging fruit'
- (2017) Paul J. Carter et al. NATURE REVIEWS DRUG DISCOVERY
- Strategies and challenges for the next generation of antibody–drug conjugates
- (2017) Alain Beck et al. NATURE REVIEWS DRUG DISCOVERY
- Enzymatic conjugation using branched linkers for constructing homogeneous antibody–drug conjugates with high potency
- (2017) Yasuaki Anami et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs)
- (2017) Ricarda M. Hoffmann et al. OncoImmunology
- Determination of Cellular Processing Rates for a Trastuzumab-Maytansinoid Antibody-Drug Conjugate (ADC) Highlights Key Parameters for ADC Design
- (2016) Katie F. Maass et al. AAPS Journal
- Multiscale Modeling of Antibody-Drug Conjugates: Connecting Tissue and Cellular Distribution to Whole Animal Pharmacokinetics and Potential Implications for Efficacy
- (2016) Cornelius Cilliers et al. AAPS Journal
- Where Did the Linker-Payload Go? A Quantitative Investigation on the Destination of the Released Linker-Payload from an Antibody-Drug Conjugate with a Maleimide Linker in Plasma
- (2016) Cong Wei et al. ANALYTICAL CHEMISTRY
- Custom-Designed Affinity Capture LC-MS F(ab′)2 Assay for Biotransformation Assessment of Site-Specific Antibody Drug Conjugates
- (2016) Dian Su et al. ANALYTICAL CHEMISTRY
- From Anthramycin to Pyrrolobenzodiazepine (PBD)-Containing Antibody-Drug Conjugates (ADCs)
- (2016) Julia Mantaj et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Orthogonal Cysteine Protection Enables Homogeneous Multi-Drug Antibody-Drug Conjugates
- (2016) Matthew R. Levengood et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Site-Specific Conjugation of Peptides and Proteins via Rebridging of Disulfide Bonds Using the Thiol–Yne Coupling Reaction
- (2016) Nils Griebenow et al. BIOCONJUGATE CHEMISTRY
- One-Step Conjugation Method for Site-Specific Antibody–Drug Conjugates through Reactive Cysteine-Engineered Antibodies
- (2016) Daisuke Shinmi et al. BIOCONJUGATE CHEMISTRY
- Characterization and Higher-Order Structure Assessment of an Interchain Cysteine-Based ADC: Impact of Drug Loading and Distribution on the Mechanism of Aggregation
- (2016) Jianxin Guo et al. BIOCONJUGATE CHEMISTRY
- Development of Solid-Phase Site-Specific Conjugation and Its Application toward Generation of Dual Labeled Antibody and Fab Drug Conjugates
- (2016) Sujiet Puthenveetil et al. BIOCONJUGATE CHEMISTRY
- Antibody-drug conjugates—an emerging class of cancer treatment
- (2016) Nikolaos Diamantis et al. BRITISH JOURNAL OF CANCER
- Mathematical Models for Immunology: Current State of the Art and Future Research Directions
- (2016) Raluca Eftimie et al. BULLETIN OF MATHEMATICAL BIOLOGY
- A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
- (2016) John Y. Li et al. CANCER CELL
- Intracellular Released Payload Influences Potency and Bystander-Killing Effects of Antibody-Drug Conjugates in Preclinical Models
- (2016) F. Li et al. CANCER RESEARCH
- Regulatory T cells in cancer immunotherapy
- (2016) Atsushi Tanaka et al. CELL RESEARCH
- Liver Microvascular Injury and Thrombocytopenia of Antibody–Calicheamicin Conjugates in Cynomolgus Monkeys—Mechanism and Monitoring
- (2016) Magali Guffroy et al. CLINICAL CANCER RESEARCH
- New developments for antibody-drug conjugate-based therapeutic approaches
- (2016) Bart ECG de Goeij et al. CURRENT OPINION IN IMMUNOLOGY
- The optimal dosing of gemtuzumab ozagamicin: where to go from here?
- (2016) T. de Witte et al. HAEMATOLOGICA
- The immune system and cancer evasion strategies: therapeutic concepts
- (2016) S. Muenst et al. JOURNAL OF INTERNAL MEDICINE
- Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates
- (2016) Heather Donaghy mAbs
- RN927C, a Site-Specific Trop-2 Antibody-Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor Models
- (2016) P. Strop et al. MOLECULAR CANCER THERAPEUTICS
- A New Class of Antibody-Drug Conjugates with Potent DNA Alkylating Activity
- (2016) M. L. Miller et al. MOLECULAR CANCER THERAPEUTICS
- Precision glycocalyx editing as a strategy for cancer immunotherapy
- (2016) Han Xiao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Imaging mass spectrometry for the precise design of antibody-drug conjugates
- (2016) Yuki Fujiwara et al. Scientific Reports
- The optimal dosing of gemtuzumab ozagamicin: where to go from here?
- (2016) T. de Witte et al. HAEMATOLOGICA
- Quantification of HER2 heterogeneity in breast cancer–implications for identification of sub-dominant clones for personalised treatment
- (2016) Niamh E. Buckley et al. Scientific Reports
- 2-(Maleimidomethyl)-1,3-Dioxanes (MD): a Serum-Stable Self-hydrolysable Hydrophilic Alternative to Classical Maleimide Conjugation
- (2016) Igor Dovgan et al. Scientific Reports
- Impact of TROP2 expression on prognosis in solid tumors: A Systematic Review and Meta-analysis
- (2016) Ping Zeng et al. Scientific Reports
- Antibody Drug Conjugates: Application of Quantitative Pharmacology in Modality Design and Target Selection
- (2015) S. Sadekar et al. AAPS Journal
- The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy
- (2015) Jonathan T. Sockolosky et al. ADVANCED DRUG DELIVERY REVIEWS
- Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development
- (2015) Paresh Agarwal et al. BIOCONJUGATE CHEMISTRY
- Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted Cancer Therapeutics
- (2015) Eunhee G. Kim et al. Biomolecules & Therapeutics
- Antibody-drug conjugates as novel anti-cancer chemotherapeutics
- (2015) C. Peters et al. BIOSCIENCE REPORTS
- Current methods for the synthesis of homogeneous antibody–drug conjugates
- (2015) Alicja M. Sochaj et al. BIOTECHNOLOGY ADVANCES
- SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the Cytoplasm
- (2015) K. J. Hamblett et al. CANCER RESEARCH
- Stabilization of cysteine-linked antibody drug conjugates with N-aryl maleimides
- (2015) R. James Christie et al. JOURNAL OF CONTROLLED RELEASE
- A Flow Cytometric Clonogenic Assay Reveals the Single-Cell Potency of Doxorubicin
- (2015) Katie F. Maass et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Residualization Rates of Near-Infrared Dyes for the Rational Design of Molecular Imaging Agents
- (2015) Cornelius Cilliers et al. MOLECULAR IMAGING AND BIOLOGY
- Recent Advances in the Development of New Auristatins: Structural Modifications and Application in Antibody Drug Conjugates
- (2015) Andreas Maderna et al. MOLECULAR PHARMACEUTICS
- Application of Pharmacokinetic-Pharmacodynamic Modeling and Simulation for Antibody-Drug Conjugate Development
- (2015) Aman P. Singh et al. PHARMACEUTICAL RESEARCH
- Current ADC Linker Chemistry
- (2015) Nareshkumar Jain et al. PHARMACEUTICAL RESEARCH
- Trastuzumab emtansine (T-DM1) renders HER2 + breast cancer highly susceptible to CTLA-4/PD-1 blockade
- (2015) Philipp Müller et al. Science Translational Medicine
- Targeting LGR5 + cells with an antibody-drug conjugate for the treatment of colon cancer
- (2015) Melissa R. Junttila et al. Science Translational Medicine
- Abstract 664: Amanitin-based antibody-drug conjugates targeting the prostate-specific membrane antigen
- (2015) Torsten Hechler et al. CANCER RESEARCH
- A Mechanistic Tumor Penetration Model to Guide Antibody Drug Conjugate Design
- (2015) Christina Vasalou et al. PLoS One
- Immunogenicity of Antibody Drug Conjugates: Bioanalytical Methods and Monitoring Strategy for a Novel Therapeutic Modality
- (2014) M. Benjamin Hock et al. AAPS Journal
- A Mechanistic Pharmacokinetic Model Elucidating the Disposition of Trastuzumab Emtansine (T-DM1), an Antibody–Drug Conjugate (ADC) for Treatment of Metastatic Breast Cancer
- (2014) Brendan Bender et al. AAPS Journal
- Preparation of Well-Defined Antibody-Drug Conjugates through Glycan Remodeling and Strain-Promoted Azide-Alkyne Cycloadditions
- (2014) Xiuru Li et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Statistical Modeling of the Drug Load Distribution on Trastuzumab Emtansine (Kadcyla), a Lysine-Linked Antibody Drug Conjugate
- (2014) Michael T. Kim et al. BIOCONJUGATE CHEMISTRY
- Site-Specific Antibody–Drug Conjugation through Glycoengineering
- (2014) Qun Zhou et al. BIOCONJUGATE CHEMISTRY
- Practical Considerations for the Pharmacokinetic and Immunogenic Assessment of Antibody–Drug Conjugates
- (2014) Melody Sauerborn et al. BIODRUGS
- Trastuzumab emtansine: mechanisms of action and drug resistance
- (2014) Mark Barok et al. BREAST CANCER RESEARCH
- The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity
- (2014) Kea Martin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Curative Properties of Noninternalizing Antibody-Drug Conjugates Based on Maytansinoids
- (2014) E. Perrino et al. CANCER RESEARCH
- PK/TD modeling for prediction of the effects of 8C2, an anti-topotecan mAb, on topotecan-induced toxicity in mice
- (2014) Dhaval K. Shah et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Comparative clinical pharmacokinetics of antibody-drug conjugates in first-in-human Phase 1 studies
- (2014) Antoine Deslandes mAbs
- Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates
- (2014) Robert P Lyon et al. NATURE BIOTECHNOLOGY
- Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry
- (2014) Charlotte Giesen et al. NATURE METHODS
- The immune checkpoint inhibitors: where are we now?
- (2014) Rachel M. Webster NATURE REVIEWS DRUG DISCOVERY
- Next generation maleimides enable the controlled assembly of antibody–drug conjugates via native disulfide bond bridging
- (2014) Felix F. Schumacher et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for THIOMAB™ Drug Conjugates
- (2014) Siddharth Sukumaran et al. PHARMACEUTICAL RESEARCH
- Microtubule-Depolymerizing Agents Used in Antibody-Drug Conjugates Induce Antitumor Immunity by Stimulation of Dendritic Cells
- (2014) P. Muller et al. Cancer Immunology Research
- An Antibody-Drug Conjugate That Targets Tissue Factor Exhibits Potent Therapeutic Activity against a Broad Range of Solid Tumors
- (2013) E. C. W. Breij et al. CANCER RESEARCH
- Antibody–drug conjugates: current status and future directions
- (2013) Heidi L. Perez et al. DRUG DISCOVERY TODAY
- Impact of Tumor HER2/ERBB2 Expression Level on HER2-Targeted Liposomal Doxorubicin-Mediated Drug Delivery: Multiple Low-Affinity Interactions Lead to a Threshold Effect
- (2013) B. S. Hendriks et al. MOLECULAR CANCER THERAPEUTICS
- Many faces of DAMPs in cancer therapy
- (2013) O Krysko et al. Cell Death & Disease
- Drugging Topoisomerases: Lessons and Challenges
- (2012) Yves Pommier ACS Chemical Biology
- Bench to bedside translation of antibody drug conjugates using a multiscale mechanistic PK/PD model: a case study with brentuximab-vedotin
- (2012) Dhaval K. Shah et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Influence of Affinity and Antigen Internalization on the Uptake and Penetration of Anti-HER2 Antibodies in Solid Tumors
- (2011) S. I. Rudnick et al. CANCER RESEARCH
- Therapeutic Mechanism and Efficacy of the Antibody-Drug Conjugate BAY 79-4620 Targeting Human Carbonic Anhydrase 9
- (2011) H. M. Petrul et al. MOLECULAR CANCER THERAPEUTICS
- The distribution of the therapeutic monoclonal antibodies cetuximab and trastuzumab within solid tumors
- (2010) Carol M Lee et al. BMC CANCER
- Modeling the efficacy of trastuzumab-DM1, an antibody drug conjugate, in mice
- (2010) Nelson L. Jumbe et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- HAHA – nothing to laugh about. Measuring the immunogenicity (human anti-human antibody response) induced by humanized monoclonal antibodies applying ELISA and SPR technology
- (2009) Andreas Nechansky JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearance
- (2008) Greg M. Thurber et al. ADVANCED DRUG DELIVERY REVIEWS
- Quantitative Spatiotemporal Analysis of Antibody Fragment Diffusion and Endocytic Consumption in Tumor Spheroids
- (2008) G. M. Thurber et al. CANCER RESEARCH
- Effect of antigen turnover rate and expression level on antibody penetration into tumor spheroids
- (2008) M. E. Ackerman et al. MOLECULAR CANCER THERAPEUTICS
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
- (2008) Jagath R Junutula et al. NATURE BIOTECHNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More